For oral use.
Treatment commences with one white tablet daily for the first 14 days followed by one grey tablet daily for the next 14 days, as directed on the 28 day calendar pack.
Femoston 1/10 should be taken continuously without a break between packs.
For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also Precautions) should be used.
Patients changing from another continuous sequential or cyclical preparation should complete the 28 day cycle and then change to Femoston 1/10.
Patients changing from a continuous combined preparation may start therapy at any time.
Depending on the clinical response, the dosage can subsequently be adjusted.
If a dose has been forgotten, it should be taken as soon as possible. If more than 12 hours have elapsed, treatment should be continued with the next tablet without taking the forgotten tablet.
The likelihood of breakthrough bleeding or spotting may be increased.
Femoston 1/10 can be taken irrespective of food intake.
Paediatric population: There is no relevant indication for the use of Femoston 1/10 in the paediatric population.